A labile point in mutant amphotericin polyketide synthases

Biotechnol Lett. 2011 Jun;33(6):1121-6. doi: 10.1007/s10529-011-0538-3. Epub 2011 Jan 26.

Abstract

Streptomyces nodosus produces the antifungal polyene amphotericin B. Numerous modifications of the amphotericin polyketide synthase have yielded new analogues. However, previous inactivation of the ketoreductase in module 10 resulted in biosynthesis of truncated polyketides. Here we show that modules downstream of this domain remain intact. Therefore, loss of ketoreductase-10 activity is sufficient to cause early chain termination. This modification creates a labile point in cycle 11 of the polyketide biosynthetic pathway. Non-extendable intermediates are released to accumulate as polyenyl-pyrones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / analogs & derivatives
  • Amphotericin B / biosynthesis*
  • Amphotericin B / chemistry
  • Antifungal Agents / metabolism
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Biotechnology
  • Genes, Bacterial
  • Molecular Structure
  • Mutation
  • Polyketide Synthases / chemistry
  • Polyketide Synthases / genetics*
  • Polyketide Synthases / metabolism*
  • Protein Engineering
  • Streptomyces / enzymology
  • Streptomyces / genetics

Substances

  • Antifungal Agents
  • Bacterial Proteins
  • Polyketide Synthases
  • Amphotericin B